Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Cellebrite DI Ltd. (CLBT)

7.56   0.01 (0.13%) 09-28 16:00
Open: 7.56 Pre. Close: 7.55
High: 7.615 Low: 7.45
Volume: 307,193 Market Cap: 1,492(M)

Technical analysis

as of: 2023-09-28 4:49:38 PM
Short-term rate:       
Stoxline posted a BUY today, downgraded from strong buy. Upward movement continues, but could change at any time.
Mid-term rate:       
Target: Six months: 9.14     One year: 9.67
Support: Support1: 7.09    Support2: 5.9
Resistance: Resistance1: 7.83    Resistance2: 8.28
Pivot: 7.46
Moving Average: MA(5): 7.48     MA(20): 7.61
MA(100): 6.92     MA(250): 5.79
MACD: MACD(12,26): -0.1     Signal(9): -0.1
Stochastic oscillator: %K(14,3): 40.4     %D(3): 34.6
RSI: RSI(14): 50.5
52-week: High: 8.28  Low: 3.79
Average Vol(K): 3-Month: 408 (K)  10-Days: 437 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently below mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.
[ CLBT ] has closed below upper band by 33.3%. Bollinger Bands are 34.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 7.62 - 7.66 7.66 - 7.69
Low: 7.37 - 7.41 7.41 - 7.44
Close: 7.51 - 7.56 7.56 - 7.61

Company Description

Cellebrite DI Ltd. develops solutions for legally sanctioned investigations. Its DI platform allows users to collect, review, analyze, and manage digital data across the investigative lifecycle with respect to legally sanctioned investigations and solutions are used in a various case, including child exploitation, homicide, anti-terror, border control, sexual crimes, human trafficking, corporate security, intellectual property theft, and civil litigation. The company's Universal Forensic Extraction Device solution addresses problems in accessing digital information, including complicated device locks, encryption barriers, deleted and unknown content, and other obstacles that can prevent critical evidence from coming to light. It also offers Seeker solution that provides the ability to analyze video footage; OSINT Analyze, a real-time deep dive solution used to analyze open-source information, such as the surface web, deep web, and the dark web; and Crypto Tracer, which analyzes blockchain transactions together with related data from an extensive list of sources to identify and categorize wallets, and transactions. The company serves federal and state and local agencies, as well as enterprise companies and service providers. It has operations in the United States, Germany, Singapore, Australia, Brazil, United Kingdom, France, Canada, Japan, and India. The company was incorporated in 1999 and is based in Petah Tikva, Israel. Cellebrite Mobile Synchronization Ltd. operates as a subsidiary of Sun Corporation.

Headline News

Tue, 12 Sep 2023
Should You Buy Cellebrite DI Ltd (CLBT) Stock Tuesday? - InvestorsObserver

Mon, 21 Aug 2023
Cellebrite Supercharges Corporate Investigative Capabilities with ... - GlobeNewswire

Sun, 13 Aug 2023
Is Cellebrite DI Ltd. (CLBT) a Good Growth Stock? - Yahoo Finance

Tue, 08 Aug 2023
Cellebrite Appoints Thomas E. Hogan as Executive Chairman of the Board - Yahoo Finance

Mon, 07 Aug 2023
Cellebrite Wins Five Forensic Focus 4:cast Awards, Reinforcing Standing as Digital Intelligence Leader - Yahoo Finance

Mon, 22 May 2023
Should You Invest in Cellebrite DI Ltd. (CLBT)? - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Outperform
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Technology
Industry:  Software—Infrastructure
Shares Out. 197 (M)
Shares Float 44 (M)
% Held by Insiders 68.7 (%)
% Held by Institutions 21 (%)
Shares Short 2,360 (K)
Shares Short P.Month 2,460 (K)

Stock Financials

EPS -0.22
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0.09
Profit Margin (%) -13.7
Operating Margin (%) 6.4
Return on Assets (ttm) 3.1
Return on Equity (ttm) -196.1
Qtrly Rev. Growth 42.9
Gross Profit (p.s.) 1.11
Sales Per Share 1.51
EBITDA (p.s.) 0.14
Qtrly Earnings Growth 0
Operating Cash Flow 64 (M)
Levered Free Cash Flow 49 (M)

Stock Valuations

PE Ratio -34.37
PEG Ratio 0.8
Price to Book value 83.99
Price to Sales 4.99
Price to Cash Flow 23.22

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.